Owner Pfizer Limited

Inventors Gibson, Karl Richard; Green, Martin Peter; Underwood, Toby James; Wakenhut, Florian

Agent Spruson & Ferguson

Pub. Number AU-B-2009294290

PCT Pub. Number WO2010/032200

Priority 61/097,902 18.09.08 US

Filing date 16 September 2009

Wipo publication date 25 March 2010

Acceptance publication date 30 August 2012

C07D 231/14 Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

A61K 31/4155 - not condensed and containing further heterocyclic rings

A61K 31/506 - not condensed and containing further heterocyclic rings

A61P 5/34 Drugs for disorders of the endocrine system

C07D 231/16 Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

C07D 403/12 Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 405/04 Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 405/12 Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 409/12 Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 471/04 Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

C07D 487/04 Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups